What the studies show
A GHK-Cu gel was tested on diabetic foot ulcers in the 1990s with mixed results; the product was not carried forward.
A few small or poorly-controlled human studies. Enough to be interesting; not enough to count on. Most of what gets called “clinically proven” online lives here.
- 1Mulder GD, et al. Enhanced healing of ulcers in patients with diabetes by topical treatment with glycyl-L-histidyl-L-lysine copper.Wound Repair Regen, 1994;2:259–269Small trial of a GHK-Cu gel on diabetic foot ulcers.
In context
GHK-Cu is a naturally occurring three-amino-acid peptide that binds copper, found in plasma, saliva and urine, with levels that fall with age. Applied to skin in creams it has modest evidence from small trials for improving fine lines and skin firmness, which is why it is a common cosmetic ingredient. Injected use — increasingly promoted online — has no human evidence of any kind.
GHK-Cu is cosmetic ingredient. Legal status differs by country — see the regulation section or the jurisdiction pages.
Questions
Is GHK-Cu proven to help with wound healing?
What studies are behind the grade?
Is GHK-Cu approved for this?
Other outcomes for GHK-Cu
- CSkin appearance (topical)3–4 small trials
- DHair growthNone controlled
- DAny outcome (injected)None
Reviewed 2 September 2026. Grades count human evidence only; see how LYO grades. Not medical advice. Correct this page →